Report Overview
Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.
The global Multiple Myeloma Therapeutics market size was estimated at USD 27270 million in 2023 and is projected to reach USD 67527.59 million by 2032, exhibiting a CAGR of 10.60% during the forecast period.
North America Multiple Myeloma Therapeutics market size was estimated at USD 8455.66 million in 2023, at a CAGR of 9.09% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Multiple Myeloma Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Multiple Myeloma Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Multiple Myeloma Therapeutics market in any manner.
Global Multiple Myeloma Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Janssen Biotech
Inc.
Bristol-Myers Squibb
Novartis AG
Bristol-Myers Squibb Company
Millennium Pharmaceuticals
Celgene Corporation
Kesios Therapeutics Limited
Amgene
Inc.
Genzyme Corporation
Juno Therapeutics
Market Segmentation (by Type)
Chemotherapy
Radiation
Stem Cell Transplant
Other Supportive Treatments
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Multiple Myeloma Therapeutics Market
Overview of the regional outlook of the Multiple Myeloma Therapeutics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Multiple Myeloma Therapeutics
1.2 Key Market Segments
1.2.1 Multiple Myeloma Therapeutics Segment by Type
1.2.2 Multiple Myeloma Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Multiple Myeloma Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Multiple Myeloma Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Multiple Myeloma Therapeutics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Multiple Myeloma Therapeutics Market Competitive Landscape
3.1 Global Multiple Myeloma Therapeutics Sales by Manufacturers (2019-2025)
3.2 Global Multiple Myeloma Therapeutics Revenue Market Share by Manufacturers (2019-2025)
3.3 Multiple Myeloma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Multiple Myeloma Therapeutics Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Multiple Myeloma Therapeutics Sales Sites, Area Served, Product Type
3.6 Multiple Myeloma Therapeutics Market Competitive Situation and Trends
3.6.1 Multiple Myeloma Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Multiple Myeloma Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Multiple Myeloma Therapeutics Industry Chain Analysis
4.1 Multiple Myeloma Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Multiple Myeloma Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Multiple Myeloma Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Multiple Myeloma Therapeutics Sales Market Share by Type (2019-2025)
6.3 Global Multiple Myeloma Therapeutics Market Size Market Share by Type (2019-2025)
6.4 Global Multiple Myeloma Therapeutics Price by Type (2019-2025)
7 Multiple Myeloma Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Multiple Myeloma Therapeutics Market Sales by Application (2019-2025)
7.3 Global Multiple Myeloma Therapeutics Market Size (M USD) by Application (2019-2025)
7.4 Global Multiple Myeloma Therapeutics Sales Growth Rate by Application (2019-2025)
8 Multiple Myeloma Therapeutics Market Consumption by Region
8.1 Global Multiple Myeloma Therapeutics Sales by Region
8.1.1 Global Multiple Myeloma Therapeutics Sales by Region
8.1.2 Global Multiple Myeloma Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Multiple Myeloma Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Multiple Myeloma Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Multiple Myeloma Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Multiple Myeloma Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Multiple Myeloma Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Multiple Myeloma Therapeutics Market Production by Region
9.1 Global Production of Multiple Myeloma Therapeutics by Region (2019-2025)
9.2 Global Multiple Myeloma Therapeutics Revenue Market Share by Region (2019-2025)
9.3 Global Multiple Myeloma Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Multiple Myeloma Therapeutics Production
9.4.1 North America Multiple Myeloma Therapeutics Production Growth Rate (2019-2025)
9.4.2 North America Multiple Myeloma Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Multiple Myeloma Therapeutics Production
9.5.1 Europe Multiple Myeloma Therapeutics Production Growth Rate (2019-2025)
9.5.2 Europe Multiple Myeloma Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Multiple Myeloma Therapeutics Production (2019-2025)
9.6.1 Japan Multiple Myeloma Therapeutics Production Growth Rate (2019-2025)
9.6.2 Japan Multiple Myeloma Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Multiple Myeloma Therapeutics Production (2019-2025)
9.7.1 China Multiple Myeloma Therapeutics Production Growth Rate (2019-2025)
9.7.2 China Multiple Myeloma Therapeutics Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Janssen Biotech
10.1.1 Janssen Biotech Multiple Myeloma Therapeutics Basic Information
10.1.2 Janssen Biotech Multiple Myeloma Therapeutics Product Overview
10.1.3 Janssen Biotech Multiple Myeloma Therapeutics Product Market Performance
10.1.4 Janssen Biotech Business Overview
10.1.5 Janssen Biotech Multiple Myeloma Therapeutics SWOT Analysis
10.1.6 Janssen Biotech Recent Developments
10.2 Inc.
10.2.1 Inc. Multiple Myeloma Therapeutics Basic Information
10.2.2 Inc. Multiple Myeloma Therapeutics Product Overview
10.2.3 Inc. Multiple Myeloma Therapeutics Product Market Performance
10.2.4 Inc. Business Overview
10.2.5 Inc. Multiple Myeloma Therapeutics SWOT Analysis
10.2.6 Inc. Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Multiple Myeloma Therapeutics Basic Information
10.3.2 Bristol-Myers Squibb Multiple Myeloma Therapeutics Product Overview
10.3.3 Bristol-Myers Squibb Multiple Myeloma Therapeutics Product Market Performance
10.3.4 Bristol-Myers Squibb Multiple Myeloma Therapeutics SWOT Analysis
10.3.5 Bristol-Myers Squibb Business Overview
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 Novartis AG
10.4.1 Novartis AG Multiple Myeloma Therapeutics Basic Information
10.4.2 Novartis AG Multiple Myeloma Therapeutics Product Overview
10.4.3 Novartis AG Multiple Myeloma Therapeutics Product Market Performance
10.4.4 Novartis AG Business Overview
10.4.5 Novartis AG Recent Developments
10.5 Bristol-Myers Squibb Company
10.5.1 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Basic Information
10.5.2 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product Overview
10.5.3 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product Market Performance
10.5.4 Bristol-Myers Squibb Company Business Overview
10.5.5 Bristol-Myers Squibb Company Recent Developments
10.6 Millennium Pharmaceuticals
10.6.1 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Basic Information
10.6.2 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product Overview
10.6.3 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product Market Performance
10.6.4 Millennium Pharmaceuticals Business Overview
10.6.5 Millennium Pharmaceuticals Recent Developments
10.7 Celgene Corporation
10.7.1 Celgene Corporation Multiple Myeloma Therapeutics Basic Information
10.7.2 Celgene Corporation Multiple Myeloma Therapeutics Product Overview
10.7.3 Celgene Corporation Multiple Myeloma Therapeutics Product Market Performance
10.7.4 Celgene Corporation Business Overview
10.7.5 Celgene Corporation Recent Developments
10.8 Kesios Therapeutics Limited
10.8.1 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Basic Information
10.8.2 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product Overview
10.8.3 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product Market Performance
10.8.4 Kesios Therapeutics Limited Business Overview
10.8.5 Kesios Therapeutics Limited Recent Developments
10.9 Amgene
10.9.1 Amgene Multiple Myeloma Therapeutics Basic Information
10.9.2 Amgene Multiple Myeloma Therapeutics Product Overview
10.9.3 Amgene Multiple Myeloma Therapeutics Product Market Performance
10.9.4 Amgene Business Overview
10.9.5 Amgene Recent Developments
10.10 Inc.
10.10.1 Inc. Multiple Myeloma Therapeutics Basic Information
10.10.2 Inc. Multiple Myeloma Therapeutics Product Overview
10.10.3 Inc. Multiple Myeloma Therapeutics Product Market Performance
10.10.4 Inc. Business Overview
10.10.5 Inc. Recent Developments
10.11 Genzyme Corporation
10.11.1 Genzyme Corporation Multiple Myeloma Therapeutics Basic Information
10.11.2 Genzyme Corporation Multiple Myeloma Therapeutics Product Overview
10.11.3 Genzyme Corporation Multiple Myeloma Therapeutics Product Market Performance
10.11.4 Genzyme Corporation Business Overview
10.11.5 Genzyme Corporation Recent Developments
10.12 Juno Therapeutics
10.12.1 Juno Therapeutics Multiple Myeloma Therapeutics Basic Information
10.12.2 Juno Therapeutics Multiple Myeloma Therapeutics Product Overview
10.12.3 Juno Therapeutics Multiple Myeloma Therapeutics Product Market Performance
10.12.4 Juno Therapeutics Business Overview
10.12.5 Juno Therapeutics Recent Developments
11 Multiple Myeloma Therapeutics Market Forecast by Region
11.1 Global Multiple Myeloma Therapeutics Market Size Forecast
11.2 Global Multiple Myeloma Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Multiple Myeloma Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Multiple Myeloma Therapeutics Market Size Forecast by Region
11.2.4 South America Multiple Myeloma Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Multiple Myeloma Therapeutics by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Multiple Myeloma Therapeutics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Multiple Myeloma Therapeutics by Type (2025-2032)
12.1.2 Global Multiple Myeloma Therapeutics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Multiple Myeloma Therapeutics by Type (2025-2032)
12.2 Global Multiple Myeloma Therapeutics Market Forecast by Application (2025-2032)
12.2.1 Global Multiple Myeloma Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Multiple Myeloma Therapeutics Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Multiple Myeloma Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Multiple Myeloma Therapeutics Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Multiple Myeloma Therapeutics Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Multiple Myeloma Therapeutics Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Multiple Myeloma Therapeutics Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapeutics as of 2022)
Table 10. Global Market Multiple Myeloma Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Multiple Myeloma Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Multiple Myeloma Therapeutics Product Type
Table 13. Global Multiple Myeloma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Multiple Myeloma Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Multiple Myeloma Therapeutics Market Challenges
Table 22. Global Multiple Myeloma Therapeutics Sales by Type (K Units)
Table 23. Global Multiple Myeloma Therapeutics Market Size by Type (M USD)
Table 24. Global Multiple Myeloma Therapeutics Sales (K Units) by Type (2019-2025)
Table 25. Global Multiple Myeloma Therapeutics Sales Market Share by Type (2019-2025)
Table 26. Global Multiple Myeloma Therapeutics Market Size (M USD) by Type (2019-2025)
Table 27. Global Multiple Myeloma Therapeutics Market Size Share by Type (2019-2025)
Table 28. Global Multiple Myeloma Therapeutics Price (USD/Unit) by Type (2019-2025)
Table 29. Global Multiple Myeloma Therapeutics Sales (K Units) by Application
Table 30. Global Multiple Myeloma Therapeutics Market Size by Application
Table 31. Global Multiple Myeloma Therapeutics Sales by Application (2019-2025) & (K Units)
Table 32. Global Multiple Myeloma Therapeutics Sales Market Share by Application (2019-2025)
Table 33. Global Multiple Myeloma Therapeutics Sales by Application (2019-2025) & (M USD)
Table 34. Global Multiple Myeloma Therapeutics Market Share by Application (2019-2025)
Table 35. Global Multiple Myeloma Therapeutics Sales Growth Rate by Application (2019-2025)
Table 36. Global Multiple Myeloma Therapeutics Sales by Region (2019-2025) & (K Units)
Table 37. Global Multiple Myeloma Therapeutics Sales Market Share by Region (2019-2025)
Table 38. North America Multiple Myeloma Therapeutics Sales by Country (2019-2025) & (K Units)
Table 39. Europe Multiple Myeloma Therapeutics Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Multiple Myeloma Therapeutics Sales by Region (2019-2025) & (K Units)
Table 41. South America Multiple Myeloma Therapeutics Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Multiple Myeloma Therapeutics Sales by Region (2019-2025) & (K Units)
Table 43. Global Multiple Myeloma Therapeutics Production (K Units) by Region (2019-2025)
Table 44. Global Multiple Myeloma Therapeutics Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Multiple Myeloma Therapeutics Revenue Market Share by Region (2019-2025)
Table 46. Global Multiple Myeloma Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Multiple Myeloma Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Multiple Myeloma Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Multiple Myeloma Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Multiple Myeloma Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Janssen Biotech Multiple Myeloma Therapeutics Basic Information
Table 52. Janssen Biotech Multiple Myeloma Therapeutics Product Overview
Table 53. Janssen Biotech Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Janssen Biotech Business Overview
Table 55. Janssen Biotech Multiple Myeloma Therapeutics SWOT Analysis
Table 56. Janssen Biotech Recent Developments
Table 57. Inc. Multiple Myeloma Therapeutics Basic Information
Table 58. Inc. Multiple Myeloma Therapeutics Product Overview
Table 59. Inc. Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Inc. Business Overview
Table 61. Inc. Multiple Myeloma Therapeutics SWOT Analysis
Table 62. Inc. Recent Developments
Table 63. Bristol-Myers Squibb Multiple Myeloma Therapeutics Basic Information
Table 64. Bristol-Myers Squibb Multiple Myeloma Therapeutics Product Overview
Table 65. Bristol-Myers Squibb Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Bristol-Myers Squibb Multiple Myeloma Therapeutics SWOT Analysis
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. Novartis AG Multiple Myeloma Therapeutics Basic Information
Table 70. Novartis AG Multiple Myeloma Therapeutics Product Overview
Table 71. Novartis AG Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Novartis AG Business Overview
Table 73. Novartis AG Recent Developments
Table 74. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Basic Information
Table 75. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product Overview
Table 76. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Bristol-Myers Squibb Company Business Overview
Table 78. Bristol-Myers Squibb Company Recent Developments
Table 79. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Basic Information
Table 80. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product Overview
Table 81. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Millennium Pharmaceuticals Business Overview
Table 83. Millennium Pharmaceuticals Recent Developments
Table 84. Celgene Corporation Multiple Myeloma Therapeutics Basic Information
Table 85. Celgene Corporation Multiple Myeloma Therapeutics Product Overview
Table 86. Celgene Corporation Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Celgene Corporation Business Overview
Table 88. Celgene Corporation Recent Developments
Table 89. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Basic Information
Table 90. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product Overview
Table 91. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Kesios Therapeutics Limited Business Overview
Table 93. Kesios Therapeutics Limited Recent Developments
Table 94. Amgene Multiple Myeloma Therapeutics Basic Information
Table 95. Amgene Multiple Myeloma Therapeutics Product Overview
Table 96. Amgene Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Amgene Business Overview
Table 98. Amgene Recent Developments
Table 99. Inc. Multiple Myeloma Therapeutics Basic Information
Table 100. Inc. Multiple Myeloma Therapeutics Product Overview
Table 101. Inc. Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Inc. Business Overview
Table 103. Inc. Recent Developments
Table 104. Genzyme Corporation Multiple Myeloma Therapeutics Basic Information
Table 105. Genzyme Corporation Multiple Myeloma Therapeutics Product Overview
Table 106. Genzyme Corporation Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Genzyme Corporation Business Overview
Table 108. Genzyme Corporation Recent Developments
Table 109. Juno Therapeutics Multiple Myeloma Therapeutics Basic Information
Table 110. Juno Therapeutics Multiple Myeloma Therapeutics Product Overview
Table 111. Juno Therapeutics Multiple Myeloma Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Juno Therapeutics Business Overview
Table 113. Juno Therapeutics Recent Developments
Table 114. Global Multiple Myeloma Therapeutics Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Multiple Myeloma Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Multiple Myeloma Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Multiple Myeloma Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Multiple Myeloma Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Multiple Myeloma Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Multiple Myeloma Therapeutics Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Multiple Myeloma Therapeutics Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Multiple Myeloma Therapeutics Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Multiple Myeloma Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Multiple Myeloma Therapeutics Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Multiple Myeloma Therapeutics Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Multiple Myeloma Therapeutics Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Multiple Myeloma Therapeutics Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Multiple Myeloma Therapeutics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Multiple Myeloma Therapeutics Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Multiple Myeloma Therapeutics Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Multiple Myeloma Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Multiple Myeloma Therapeutics Market Size (M USD), 2019-2032
Figure 5. Global Multiple Myeloma Therapeutics Market Size (M USD) (2019-2032)
Figure 6. Global Multiple Myeloma Therapeutics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Multiple Myeloma Therapeutics Market Size by Country (M USD)
Figure 11. Multiple Myeloma Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Multiple Myeloma Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Multiple Myeloma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Multiple Myeloma Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Multiple Myeloma Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Multiple Myeloma Therapeutics Market Share by Type
Figure 18. Sales Market Share of Multiple Myeloma Therapeutics by Type (2019-2025)
Figure 19. Sales Market Share of Multiple Myeloma Therapeutics by Type in 2023
Figure 20. Market Size Share of Multiple Myeloma Therapeutics by Type (2019-2025)
Figure 21. Market Size Market Share of Multiple Myeloma Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Multiple Myeloma Therapeutics Market Share by Application
Figure 24. Global Multiple Myeloma Therapeutics Sales Market Share by Application (2019-2025)
Figure 25. Global Multiple Myeloma Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Multiple Myeloma Therapeutics Market Share by Application (2019-2025)
Figure 27. Global Multiple Myeloma Therapeutics Market Share by Application in 2023
Figure 28. Global Multiple Myeloma Therapeutics Sales Growth Rate by Application (2019-2025)
Figure 29. Global Multiple Myeloma Therapeutics Sales Market Share by Region (2019-2025)
Figure 30. North America Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Multiple Myeloma Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Multiple Myeloma Therapeutics Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Multiple Myeloma Therapeutics Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Multiple Myeloma Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Multiple Myeloma Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Multiple Myeloma Therapeutics Sales Market Share by Region in 2023
Figure 44. China Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Multiple Myeloma Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Multiple Myeloma Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Multiple Myeloma Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Multiple Myeloma Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Multiple Myeloma Therapeutics Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Multiple Myeloma Therapeutics Production Market Share by Region (2019-2025)
Figure 62. North America Multiple Myeloma Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Multiple Myeloma Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Multiple Myeloma Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 65. China Multiple Myeloma Therapeutics Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Multiple Myeloma Therapeutics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Multiple Myeloma Therapeutics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Multiple Myeloma Therapeutics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Multiple Myeloma Therapeutics Market Share Forecast by Type (2025-2032)
Figure 70. Global Multiple Myeloma Therapeutics Sales Forecast by Application (2025-2032)
Figure 71. Global Multiple Myeloma Therapeutics Market Share Forecast by Application (2025-2032)
